Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
Cartalax: Bloodwork Guide
Recommended lab tests and biomarkers to monitor before, during, and after Cartalax therapy. Testing schedules are based on clinical protocols and published monitoring guidelines.
Back to Cartalax overviewBefore Starting (2 tests)
| Biomarker | Expected Effect | Retest |
|---|---|---|
| Collagen Type II (C2C) | → normalizes | Every 12 weeks |
| MMP-3 (Matrix Metalloproteinase-3) | ↓ decreases | Every 12 weeks |